Raymond James Financial Services Advisors, Inc. Allovir, Inc. Transaction History
Raymond James Financial Services Advisors, Inc.
- $73.5 Billion
- Q3 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Allovir, Inc. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 60,500 shares of ALVR stock, worth $598,950. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60,500
Previous 60,500
-0.0%
Holding current value
$598,950
Previous $43,000
13.95%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ALVR
# of Institutions
49Shares Held
21.1MCall Options Held
41KPut Options Held
100-
Siren, L.L.C. New York, NY6.6MShares$65.3 Million0.12% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.03MShares$30 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.65MShares$26.2 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA1.91MShares$18.9 Million0.06% of portfolio
-
Jacobs Levy Equity Management, Inc Florham Park, NJ664KShares$6.58 Million0.0% of portfolio
About Allovir, Inc.
- Ticker ALVR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,063,400
- Market Cap $921M
- Description
- Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...